Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
HAIIF Haitian International Holdings Ltd
PM Philip Morris International Inc
CCLP CSI Compressco LP
CBWTF Auxly Cannabis Group Inc
FGPR Ferrellgas Partners LP
MSFT Microsoft Corp
DNKN Dunkin' Brands Group Inc
MLAIX MainStay Winslow Large Cap Growth Fund Class I
AY Atlantica Sustainable Infrastructure PLC
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Price
Delayed
$38.40
Day's Change
-0.085 (-0.22%)
Bid
--
Ask
--
B/A Size
--
Day's High
38.66
Day's Low
38.22
Volume
(Light)

Today's volume of 10,771,655 shares is on pace to be much lighter than PFE's 10-day average volume of 40,467,073 shares.

10,771,655

Display:

Providers:

UpdateCancel
6 providers
Today's News, August 03, 2020
Award-Winning Television Host Meredith Vieira Joins Pfizer's Find Your MBC Voice to Help Empower People Living with Metastatic Breast Cancer to Speak Up

Award-winning television host, executive producer and anchor, Meredith Vieira, along with five leading breast cancer patient advocacy organizations and healthcare professionals, are joining Find Your MBC Voice -- an initiative from Pfizer Inc...(PR Newswire)

ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000

ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX) (TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced the closing of an underwritten public...(PR Newswire)

July 31, 2020
Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of their BNT162 mRNA-based vaccine candidate against SARS-CoV-2, subject...(Globe Newswire)

Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV2, subject to...(BusinessWire)

July 30, 2020
Multiple Sclerosis Drugs Market to Hit USD 40.66 Bn by 2027; Promising Research into Developing Efficient MS Therapies to Prove Beneficial for the Market: Fortune Business Insights(TM)

The global multiple sclerosis drugs market size is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. High prevalence of multiple sclerosis (MS) worldwide will be the primary factor driving the...(Globe Newswire)

Thinking about buying stock in Edesa Biotech, iBio Inc, Pfizer Inc, Lexicon Pharmaceuticals, or Apache Corp?

InvestorsObserver issues critical PriceWatch Alerts for EDSA, IBIO, PFE, LXRX, and APA. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

July 28, 2020
Thinking about trading options or stock in Pfizer, Aphria Inc, Boeing, Altria Group, or Microsoft?

InvestorsObserver issues critical PriceWatch Alerts for PFE, APHA, BA, MO, and MSFT. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Pfizer Reports Second-Quarter 2020 Results

Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2020, increased its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and reaffirmed all other components of its 2020 financial guidance, which continues to reflect...(BusinessWire)

July 27, 2020
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study

-- Companies advance nucleoside-modified messenger RNA (modRNA) candidate BNT162b2, which encodes an optimized SARS-CoV-2 full-length spike glycoprotein, at a 30 ug dose level in a 2 dose regimen into Phase 2/3 Study (Globe Newswire)

Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA (modRNA) candidate from their BNT162...(BusinessWire)

July 23, 2020
Dermatophytic Onychomycosis Treatment Market to Reach USD 6.63 Billion by 2027; Increasing Prevalence of Diabetes to Spur Business Opportunities, states Fortune Business Insights(TM)

The global dermatophytic onychomycosis treatment market size is predicted to reach USD 6.63 billion by 2027, exhibiting a CAGR of 7.4% during the forecast period. The rising prevalence of diabetes and incidences of chronic nail fungus infection...(Globe Newswire)

Thinking about buying stock in Milestone Pharmaceuticals, Advanced Micro Devices, CymaBay Therapeutics, Pfizer Inc, or AT&T?

InvestorsObserver issues critical PriceWatch Alerts for MIST, AMD, CBAY, PFE, and T. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

July 22, 2020
Data Shows Direct Link Between COVID-19 and Acute Respiratory Distress Syndrome (ARDS) In Infected Patients

There is a direct link between the COVID-19 virus and acute respiratory distress syndrome (ARDS) in COVID-19 patients. According to the National Institutes of Health about 80% of COVID-19 infections are mild or asymptomatic and never require...(PR Newswire)

Thinking about trading options or stock in Pfizer, Netflix, Ford, Snap Inc, or Norwegian Cruise Line?

InvestorsObserver issues critical PriceWatch Alerts for PFE, NFLX, F, SNAP, and NCLH. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Global Cart Cell Therapy Market To Grow At A CAGR of 29.4% With The Emergence Of Immunotherapies In Medical Treatment

The global cart cell therapy market size was valued at USD 355.1 million in 2018 and is anticipated to grow at a CAGR of 29.4% during the forecast period. For years, the foundations of cancer treatment were chemotherapy, surgery, and radiation...(Globe Newswire)

Global PARP Inhibitor Market To Grow At A CAGR Of 27.4% Due To Expanding Role Of PARP Inhibitors In Cancer Treatment

Global PARP Inhibitor Market was valued at USD 924 million in 2018 and predicted to grow at an exponential CAGR of 27.4% during the forecast period. The pharmaceutical industry offers an opportunity to PARP inhibitors market in a promising new area...(Globe Newswire)

Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

-- U. S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million additional doses -- Americans to receive the vaccine for free consistent with U.S. government's commitment for free access for...(Globe Newswire)

Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

- U. S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million additional doses - Americans to receive the vaccine for free consistent with U.S. government's commitment for free access for...(Thomson Reuters ONE)

Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government's Operation Warp Speed program goal...(BusinessWire)

July 21, 2020
Aptevo Therapeutics Engages Piper Sandler to Sell its RUXIENCE(R) and IXINITY(R) Royalty Streams & Milestones

SEATTLE, WA / ACCESSWIRE / July 21, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIRT bispecific technology platform, has engaged Piper...(Accesswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.